Alyeska Investment Group’s Health Assurance Acquisition Corp. Class A Common Stock HAAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-428,995
Closed -$4.24M 675
2022
Q2
$4.24M Hold
428,995
0.05% 312
2022
Q1
$4.23M Hold
428,995
0.05% 315
2021
Q4
$4.19M Hold
428,995
0.05% 313
2021
Q3
$4.2M Buy
428,995
+18,011
+4% +$176K 0.05% 369
2021
Q2
$4.11M Hold
410,984
0.05% 384
2021
Q1
$4.2M Buy
+410,984
New +$4.87M 0.05% 360

Other funds holding HAAC

Alyeska Investment Group's HAAC Position: Q3 2022 in Review

Alyeska Investment Group sold out of Health Assurance Acquisition Corp. Class A Common Stock (HAAC) in Q3 2022, closing a stake of 428,995 shares — an estimated $4.24M sold.

Alyeska Investment Group first reported a position in HAAC in Q1 2021 and held it in 6 quarters. The position peaked at $4.24M in Q2 2022. 85 funds tracked by Wall St. Rank hold HAAC as of Q3 2022.

  • Alyeska Investment Group reported no remaining Health Assurance Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 428,995 Health Assurance Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $4.24M.
  • Alyeska Investment Group first reported a position in Health Assurance Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 6 quarters.
  • Alyeska Investment Group's Health Assurance Acquisition Corp. Class A Common Stock position peaked at $4.24M in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Health Assurance Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on Alyeska Investment Group's 13F filing for Q3 2022, filed 14 Nov 2022.